Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This project aims to study whether a structured wellness program intervention can improve quality of life among people living with Neuromyelitis Optica Spectrum Disorder (NMOSD). This pilot will test a multi-modal wellness program tailored to NMOSD patients that includes services from physical therapists, dietitians, social workers, nurse practitioners and cognitive therapists. The trial will be designed as a randomized controlled trial, randomizing patients to immediately starting the program as well as a 6 month delayed start. The intervention would leverage an existing clinical comprehensive MS wellness program at the Corinne Dickinson for Multiple Sclerosis (MS) at Mount Sinai Medical Center. The primary endpoint of this study would be evaluating quality of life, as assessed by MS-Quality of Life -54.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adults (age ≥18) with NMOSD diagnosed with 2015 NMOSD clinical criteria.

• All EDSS scores will be considered in order to make the intervention accessible to all patients regardless of disability.

• All patients regardless of treatment type will be considered.

Locations
United States
New York
Corinne Goldsmith Dickinson Center for MS at Mount Sinai
RECRUITING
New York
Contact Information
Primary
Susan Filomena
susan.filomena@mssm.edu
212-241-3841
Backup
Savannah Steer
savannah.steer@mssm.edu
212-241-4264
Time Frame
Start Date: 2025-01-21
Estimated Completion Date: 2028-01
Participants
Target number of participants: 20
Treatments
Experimental: Immediate Start
Participants will begin wellness program services and behavioral interventions immediately after randomization
Other: Delayed Start
Participants will experience a 6-month delay in receiving wellness program services and behavioral interventions.
Sponsors
Leads: Icahn School of Medicine at Mount Sinai

This content was sourced from clinicaltrials.gov

Similar Clinical Trials